Healthcare & Life Sciences
Trojan Bio
Israel
unknownseries-a
series-a
Stage
2020
Founded
2
Investors
About
Trojan Bio develops immunotherapy technology that uses antiviral immunity to target and eliminate cancer cells by marking them as virus-infected to trigger a strong immune response.
Explore Trojan Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.